The Role of Inflammatory Markers in OSAHS-Related White Matter Lesions and Asymptomatic Lacunar Infarction

CompletedOBSERVATIONAL
Enrollment

119

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions
Obstructive Sleep Apnea-hypopnea Syndrome
Interventions
DIAGNOSTIC_TEST

Polysomnography (PSG)

Participants underwent overnight polysomnography for a minimum of 7 hours using an E series polysomnography monitor. The monitoring included electroencephalogram (EEG), eye movement, Holter monitoring, airflow, chest and abdominal respiratory movements, and fingertip oxygen saturation. The results were used to diagnose Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) and calculate the Apnea-Hypopnea Index (AHI) for severity classification.

DIAGNOSTIC_TEST

Brain Magnetic Resonance Imaging (MRI)

A whole-brain scan was performed on all participants using a Philips Ingenia 3.0T MRI scanner. The scanning sequences included T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and Fluid-Attenuated Inversion Recovery (FLAIR). The images were analyzed by two neurologists to identify asymptomatic lacunar infarction and to assess the severity of white matter lesions using the Age-Related White Matter Change (ARWMC) scoring system.

DIAGNOSTIC_TEST

Serum Inflammatory Marker Measurement

Fasting venous blood (3mL) was collected from all participants on the day of their brain MRI scan. Serum was separated by centrifugation. Levels of Serum Amyloid A (SAA), Tumor Necrosis Factor-alpha (TNF-α), and Interleukin-6 (IL-6) were measured using the Enzyme-Linked Immunosorbent Assay (ELISA) method according to the manufacturer's protocols.

Trial Locations (1)

075000

The First Affiliated Hospital of Hebei North University, Zhangjiakou

All Listed Sponsors
lead

Yanpeng Li

OTHER